Literature DB >> 14646373

High dose allergen stimulation of T cells from house dust mite-allergic subjects induces expansion of IFN-gamma+ T Cells, apoptosis of CD4+IL-4+ T cells and T cell anergy.

Leanne M Gardner1, Robyn E O'Hehir, Jennifer M Rolland.   

Abstract

BACKGROUND: During clinically effective allergen-specific immunotherapy a shift in cytokine dominance from IL-4, IL-5 predominant to IFN-gamma predominant has been observed. As antigen concentration influences Th cell priming, this study aimed to determine the effect of different allergen concentrations on human house dust mite (HDM)-specific T cell production of IL-4 and IFN-gamma, proliferation and apoptosis.
METHODS: HDM-allergic donor PBMC were cultured for 14 days with different concentrations of HDM extract (1, 10 and 100 microg/ml). T cell intracellular IL-4 and IFN-gamma, division (CFSE labelling) and apoptosis (active caspase-3 staining) were analysed by flow cytometry. Proliferation was assessed by (3)H-thymidine incorporation.
RESULTS: Increased CD4+IFN-gamma+ and CD8+IFN-gamma+ T cell numbers were observed in high allergen concentration cultures compared with low concentration cultures whereas there were no differences in CD4+IL-4+ and CD8+IL-4+ T cell numbers. CFSE cell labelling revealed that high allergen concentration favours the expansion of IFN-gamma-producing CD4+ T cells. The proportion of apoptotic cells increased with allergen concentration and there was preferential apoptosis of CD4+IL-4+ T cells. HDM-induced proliferation was decreased in high allergen concentration cultures; this was reversible by IL-2 consistent with anergy.
CONCLUSION: These results show that T cell division and apoptosis contribute to the cytokine skewing to predominant IFN-gamma production by T cells observed at high allergen concentration. Thus the use of hypoallergenic T cell reactive preparations which can be given safely at higher doses than natural extracts may enhance efficacy of allergen-specific immunotherapy. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646373     DOI: 10.1159/000075248

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  10 in total

Review 1.  T-cell responses induced by allergen-specific immunotherapy.

Authors:  E Maggi
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

Review 2.  Effect of allergen-specific immunotherapy on CD4+ T cells.

Authors:  Erik Wambre
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-12

3.  Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells.

Authors:  Wen Su; Wenwei Zhong; Yanjie Zhang; Zhenwei Xia
Journal:  BMC Immunol       Date:  2012-07-06       Impact factor: 3.615

4.  Therapeutic vaccines for allergic disease.

Authors:  Danuta Gutowska-Owsiak; Graham S Ogg
Journal:  NPJ Vaccines       Date:  2017-05-08       Impact factor: 7.344

Review 5.  On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).

Authors:  Martín Candia; Bernhard Kratzer; Winfried F Pickl
Journal:  Int Arch Allergy Immunol       Date:  2016-09-20       Impact factor: 2.749

Review 6.  Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity.

Authors:  Naomi Richardson; David Cameron Wraith
Journal:  Immunother Adv       Date:  2021-05-22

7.  Induction of IgG2 and IgG4 B-cell memory following sublingual immunotherapy for ryegrass pollen allergy.

Authors:  Jorn J Heeringa; Craig I McKenzie; Nirupama Varese; Mark Hew; Amy T C M Bakx; Pei M Aui; Jennifer M Rolland; Robyn E O'Hehir; Menno C van Zelm
Journal:  Allergy       Date:  2019-11-04       Impact factor: 13.146

8.  Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis.

Authors:  Minoru Gotoh; Osamu Kaminuma; Takachika Hiroi; Kimihiro Okubo
Journal:  Allergy Asthma Immunol Res       Date:  2018-09       Impact factor: 5.764

Review 9.  Allergen Immunotherapy: Current and Future Trends.

Authors:  Gandhi F Pavón-Romero; Maria Itzel Parra-Vargas; Fernando Ramírez-Jiménez; Esmeralda Melgoza-Ruiz; Nancy H Serrano-Pérez; Luis M Teran
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

10.  Heterogeneity of magnitude, allergen immunodominance, and cytokine polarization of cockroach allergen-specific T cell responses in allergic sensitized children.

Authors:  Ricardo da Silva Antunes; Aaron Sutherland; April Frazier; Veronique Schulten; Anna Pomés; Jill Glesner; Agustin Calatroni; Matthew C Altman; Robert A Wood; George T O'Connor; Jacqueline A Pongracic; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Michelle Gill; Andrew H Liu; Edward Zoratti; Meyer Kattan; Paula J Busse; Leonard B Bacharier; Stephen J Teach; Lisa M Wheatley; Alkis Togias; William W Busse; Daniel J Jackson; Alessandro Sette
Journal:  Clin Transl Allergy       Date:  2021-10-13       Impact factor: 5.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.